The use of CD4 counts as prognostic markers in HIV infection

Clinical characteristics of women with HIV in the RESPOND cohort: A descriptive analysis and comparison to men.

HIV medicine·2024

SARS-CoV-2 testing, positivity, and factors associated with COVID-19 among people with HIV across Europe in the multinational EuroSIDA cohort.

HIV medicine·2024

Healthcare delivery for HIV-positive people with tuberculosis in Europe.

HIV medicine·2020

A new health care index predicts short term mortality for TB and HIV co-infected people.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2020

Sexual risk and HIV testing disconnect in men who have sex with men (MSM) recruited to an online HIV self-testing trial.

HIV medicine·2020

Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral-naïve persons starting treatment.

HIV medicine·2020

Antiretroviral therapy regimens initiated during pregnancy and risks of adverse perinatal outcomes.

AIDS (London, England)·2026

Does where you live matter? Rurality and 30-day hospital readmission among people with HIV.

AIDS (London, England)·2026

Circulating markers of organ damage associate with COPD in people with HIV: an exploratory proteomic analysis.

AIDS (London, England)·2026

Efficacy of dolutegravir or bictegravir-containing therapy in a real-life cohort of people with HIV-1 sub-subtype A6.

AIDS (London, England)·2026

Sex-modulated associations between cytomegalovirus cell-associated DNA and cognition in people with HIV on ART.

AIDS (London, England)·2026

Clinical phenotypes and incidence of acute or recent hepatitis C virus infection and bacterial sexually transmitted infections among MSM with HIV.

AIDS (London, England)·2026

Related Experiment Videos

The use of CD4 counts as prognostic markers in HIV infection

Related Concept Videos

Clinical characteristics of women with HIV in the RESPOND cohort: A descriptive analysis and comparison to men.

SARS-CoV-2 testing, positivity, and factors associated with COVID-19 among people with HIV across Europe in the multinational EuroSIDA cohort.

Healthcare delivery for HIV-positive people with tuberculosis in Europe.

A new health care index predicts short term mortality for TB and HIV co-infected people.

Sexual risk and HIV testing disconnect in men who have sex with men (MSM) recruited to an online HIV self-testing trial.

Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral-naïve persons starting treatment.

Antiretroviral therapy regimens initiated during pregnancy and risks of adverse perinatal outcomes.

Does where you live matter? Rurality and 30-day hospital readmission among people with HIV.

Circulating markers of organ damage associate with COPD in people with HIV: an exploratory proteomic analysis.

Efficacy of dolutegravir or bictegravir-containing therapy in a real-life cohort of people with HIV-1 sub-subtype A6.

Sex-modulated associations between cytomegalovirus cell-associated DNA and cognition in people with HIV on ART.

Clinical phenotypes and incidence of acute or recent hepatitis C virus infection and bacterial sexually transmitted infections among MSM with HIV.

Related Experiment Videos

The use of CD4 counts as prognostic markers in HIV infection

Related Concept Videos

Related Articles